Cargando…

Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease

Several neurodegenerative diseases associated with protein misfolding (Alzheimer’s and Parkinson’s disease) exhibit oxidative and nitrergic stress following initiation of neuroinflammatory pathways. Associated nitric oxide (NO)-mediated posttranslational modifications impact upon protein functions t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourgognon, Julie-Myrtille, Spiers, Jereme G., Robinson, Sue W., Scheiblich, Hannah, Glynn, Paul, Ortori, Catharine, Bradley, Sophie J., Tobin, Andrew B., Steinert, Joern R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958397/
https://www.ncbi.nlm.nih.gov/pubmed/33653950
http://dx.doi.org/10.1073/pnas.2009579118
_version_ 1783664815415230464
author Bourgognon, Julie-Myrtille
Spiers, Jereme G.
Robinson, Sue W.
Scheiblich, Hannah
Glynn, Paul
Ortori, Catharine
Bradley, Sophie J.
Tobin, Andrew B.
Steinert, Joern R.
author_facet Bourgognon, Julie-Myrtille
Spiers, Jereme G.
Robinson, Sue W.
Scheiblich, Hannah
Glynn, Paul
Ortori, Catharine
Bradley, Sophie J.
Tobin, Andrew B.
Steinert, Joern R.
author_sort Bourgognon, Julie-Myrtille
collection PubMed
description Several neurodegenerative diseases associated with protein misfolding (Alzheimer’s and Parkinson’s disease) exhibit oxidative and nitrergic stress following initiation of neuroinflammatory pathways. Associated nitric oxide (NO)-mediated posttranslational modifications impact upon protein functions that can exacerbate pathology. Nonenzymatic and irreversible glycation signaling has been implicated as an underlying pathway that promotes protein misfolding, but the direct interactions between both pathways are poorly understood. Here we investigated the therapeutic potential of pharmacologically suppressing neuroinflammatory NO signaling during early disease progression of prion-infected mice. Mice were injected daily with an NO synthase (NOS) inhibitor at early disease stages, hippocampal gene and protein expression levels of oxidative and nitrergic stress markers were analyzed, and electrophysiological characterization of pyramidal CA1 neurons was performed. Increased neuroinflammatory signaling was observed in mice between 6 and 10 wk postinoculation (w.p.i.) with scrapie prion protein. Their hippocampi were characterized by enhanced nitrergic stress associated with a decline in neuronal function by 9 w.p.i. Daily in vivo administration of the NOS inhibitor L-NAME between 6 and 9 w.p.i. at 20 mg/kg prevented the functional degeneration of hippocampal neurons in prion-diseased mice. We further found that this intervention in diseased mice reduced 3-nitrotyrosination of triose-phosphate isomerase, an enzyme involved in the formation of disease-associated glycation. Furthermore, L-NAME application led to a reduced expression of the receptor for advanced glycation end-products and the diminished accumulation of hippocampal prion misfolding. Our data suggest that suppressing neuroinflammatory NO signaling slows functional neurodegeneration and reduces nitrergic and glycation-associated cellular stress.
format Online
Article
Text
id pubmed-7958397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-79583972021-03-25 Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease Bourgognon, Julie-Myrtille Spiers, Jereme G. Robinson, Sue W. Scheiblich, Hannah Glynn, Paul Ortori, Catharine Bradley, Sophie J. Tobin, Andrew B. Steinert, Joern R. Proc Natl Acad Sci U S A Biological Sciences Several neurodegenerative diseases associated with protein misfolding (Alzheimer’s and Parkinson’s disease) exhibit oxidative and nitrergic stress following initiation of neuroinflammatory pathways. Associated nitric oxide (NO)-mediated posttranslational modifications impact upon protein functions that can exacerbate pathology. Nonenzymatic and irreversible glycation signaling has been implicated as an underlying pathway that promotes protein misfolding, but the direct interactions between both pathways are poorly understood. Here we investigated the therapeutic potential of pharmacologically suppressing neuroinflammatory NO signaling during early disease progression of prion-infected mice. Mice were injected daily with an NO synthase (NOS) inhibitor at early disease stages, hippocampal gene and protein expression levels of oxidative and nitrergic stress markers were analyzed, and electrophysiological characterization of pyramidal CA1 neurons was performed. Increased neuroinflammatory signaling was observed in mice between 6 and 10 wk postinoculation (w.p.i.) with scrapie prion protein. Their hippocampi were characterized by enhanced nitrergic stress associated with a decline in neuronal function by 9 w.p.i. Daily in vivo administration of the NOS inhibitor L-NAME between 6 and 9 w.p.i. at 20 mg/kg prevented the functional degeneration of hippocampal neurons in prion-diseased mice. We further found that this intervention in diseased mice reduced 3-nitrotyrosination of triose-phosphate isomerase, an enzyme involved in the formation of disease-associated glycation. Furthermore, L-NAME application led to a reduced expression of the receptor for advanced glycation end-products and the diminished accumulation of hippocampal prion misfolding. Our data suggest that suppressing neuroinflammatory NO signaling slows functional neurodegeneration and reduces nitrergic and glycation-associated cellular stress. National Academy of Sciences 2021-03-09 2021-03-02 /pmc/articles/PMC7958397/ /pubmed/33653950 http://dx.doi.org/10.1073/pnas.2009579118 Text en Copyright © 2021 the Author(s). Published by PNAS. http://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biological Sciences
Bourgognon, Julie-Myrtille
Spiers, Jereme G.
Robinson, Sue W.
Scheiblich, Hannah
Glynn, Paul
Ortori, Catharine
Bradley, Sophie J.
Tobin, Andrew B.
Steinert, Joern R.
Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title_full Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title_fullStr Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title_full_unstemmed Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title_short Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
title_sort inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958397/
https://www.ncbi.nlm.nih.gov/pubmed/33653950
http://dx.doi.org/10.1073/pnas.2009579118
work_keys_str_mv AT bourgognonjuliemyrtille inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT spiersjeremeg inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT robinsonsuew inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT scheiblichhannah inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT glynnpaul inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT ortoricatharine inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT bradleysophiej inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT tobinandrewb inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease
AT steinertjoernr inhibitionofneuroinflammatorynitricoxidesignalingsuppressesglycationandpreventsneuronaldysfunctioninmousepriondisease